RSCM

Rock Springs Capital Management Portfolio holdings

AUM $1.71B
1-Year Est. Return 43.68%
This Quarter Est. Return
1 Year Est. Return
+43.68%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.87B
AUM Growth
+$435M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
134
New
Increased
Reduced
Closed

Top Buys

1
+$38.6M
2
+$36.8M
3
+$23.5M
4
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$20.7M
5
GOSS icon
Gossamer Bio
GOSS
+$19M

Top Sells

1
+$64.6M
2
+$20.5M
3
+$16.8M
4
AMLX icon
Amylyx Pharmaceuticals
AMLX
+$16.1M
5
EPZM
Epizyme, Inc
EPZM
+$11M

Sector Composition

1 Healthcare 96.72%
2 Consumer Staples 0.91%
3 Industrials 0.67%
4 Financials 0.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
101
$3.22M 0.08%
365,985
+690
102
$3.11M 0.08%
384,590
103
$3.1M 0.08%
309,000
104
$2.85M 0.07%
+223,255
105
$2.54M 0.07%
437,329
106
$2.53M 0.07%
2,357,544
107
$2.47M 0.06%
781,000
+19,443
108
$2.46M 0.06%
110,000
109
$2.22M 0.06%
21,636
110
$2.06M 0.05%
206,200
111
$1.92M 0.05%
210,601
112
$1.8M 0.05%
136,556
+13,675
113
$1.54M 0.04%
770,710
114
$1.53M 0.04%
55,429
+14,719
115
$1.43M 0.04%
63,358
116
$1.32M 0.03%
316,460
117
$1.05M 0.03%
+171,272
118
$955K 0.02%
524,944
119
$848K 0.02%
1,289,990
120
$726K 0.02%
462,530
121
$653K 0.02%
701,680
122
$479K 0.01%
2,719,074
-55,795
123
$27K ﹤0.01%
134,028
124
– –
-368,959
125
– –
-809,854
2 3 4
5
6